Back to Search
Start Over
Coronary sinus reducer for the treatment of refractory angina (ORBITA-COSMIC): a randomised, placebo-controlled trial
- Source :
- The Lancet; April 2024, Vol. 403 Issue: 10436 p1543-1553, 11p
- Publication Year :
- 2024
-
Abstract
- The coronary sinus reducer (CSR) is proposed to reduce angina in patients with stable coronary artery disease by improving myocardial perfusion. We aimed to measure its efficacy, compared with placebo, on myocardial ischaemia reduction and symptom improvement.
Details
- Language :
- English
- ISSN :
- 01406736 and 1474547X
- Volume :
- 403
- Issue :
- 10436
- Database :
- Supplemental Index
- Journal :
- The Lancet
- Publication Type :
- Periodical
- Accession number :
- ejs66109620
- Full Text :
- https://doi.org/10.1016/S0140-6736(24)00256-3